Strategy formulation.

As President of Putnam, Matt leads a team focused on strategic acuity and patient impact. He has partnered with global biopharma across therapeutic areas from pipeline shaping to launch, applying structured thinking and objective analysis to drive results.

Mariah translates insights from primary and secondary research into clear strategic guidance across neurology, rare diseases, oncology, and vaccines. She brings deep expertise in qualitative and quantitative methods and actionable insight development.

Varun is a physician who has been supporting biopharma clients as a strategy consultant for the past 15 years. His areas of focus are commercial strategy, growth strategy, medical affairs, and deals for life science companies worldwide.

Karan sits on Putnam’s Commercial Practice Leadership team, advising US and European biopharma on pipeline and in-line products. His focus includes go-to-market strategy, opportunity assessment, forecasting, and portfolio optimization.

Joanna provides scientific and analytical insight for pharmaceutical and biotech strategy. She brings experience across the product lifecycle, including competitive assessments, R&D prioritization, market sizing, forecasting, launch, pricing, brand strategy, with focus in oncology, hematology, and rare diseases.

Lori’s expertise spans stakeholder engagement, center-of-excellence profiling, organizational design, strategic medical launches, integrated evidence planning, omnichannel strategy, and digital health platforms including digital therapeutics, AI, and software as a medical device.